Moneycontrol PRO
HomeNewsTechnologyAutoIndia auto hub lets car plants run at full capacity despite few vaccinations

India auto hub lets car plants run at full capacity despite few vaccinations

India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

June 21, 2021 / 07:36 IST
India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

Car factories, including those of Renault-Nissan, Hyundai and Ford, can operate with full workforces in India's automaking hub from Monday, even though 75% of workers at the global carmakers' plants have not been vaccinated against COVID-19.

India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

The move follows a Tamil Nadu Directorate of Industrial Safety and Health report dated 18 June, reviewed by Reuters, which shows three in four workers at the plants of Ford, Hyundai and Renault-Nissan near Chennai have not been vaccinated against COVID-19.

Of those who were vaccinated, the report did not say how many had received one dose and how many had received two.

The report said one in seven workers in these companies had contracted the virus, and 21 had died. Workers at the three plants accounted for around 4% of cases in the two districts where the plants are located.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"Working condition in such assembly lines poses challenges in maintaining social distancing norms due to the close proximity of workforce," the report said.

Ford, Renault-Nissan and Hyundai halted work at their plants for several days last month, after workers protested and some went on strike over safety concerns.

On June 17, the Chennai plants were functioning at over 90% of workforce capacity and the cumulative output was nearly two-thirds of pre-lockdown levels, according to the report.

Hyundai, Ford and Nissan, which majority owns the Renault-Nissan Chennai plant, did not immediately respond to requests for comment.

New cases in Tamil Nadu have fallen from more than 30,000 a day in May to about 8,000 but still account for one-seventh of all cases in India, which is second only to the United States in total infections.

The report by the industrial safety department was filed in response to an Indian court tasking officials with visiting carmakers to draw up uniform safety guidelines, after workers at Renault-Nissan India filed a case asking operations be halted as social distancing norms were being flouted.

The case will be next heard on Monday.

The department recommended the speed of conveyor belts at the plants be reduced, and using idle workstations to ensure social distancing. It also recommended that workers employed in assembly lines be vaccinated as soon as possible.

Except for one of the two assembly lines at the Ford plant, the conveyor speed had not been reduced, the report said.

Following is a table showing figures from the report of vaccinations, cases, deaths and output at the three factories on June 17:

Carmaker Workers Vaccinated COVID-19 Active Deaths Cars

cases cases output

Hyundai 10532 4480 1809 52 10 1816

Ford 4449 544 670 55 5 241

Renault- 8432 966 1289 21 6 540

Nissan

Total 23413 5990 3768 128 21 2597

Reuters
first published: Jun 21, 2021 01:08 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347